King's College London, Applied Biomedical Science Research Division and Elliot-Smith Clinic, Churchill Hospital, Oxford, UK.
BJU Int. 2010 Aug;106(4):578-85. doi: 10.1111/j.1464-410X.2009.09092.x. Epub 2009 Dec 11.
To investigate the effects of the relatively selective T-type Ca(2+)-antagonists, mibefradil and flunarizine, and the L-type Ca(2+)-antagonist, nifedipine, on the contractions of longitudinal and circular muscles of human vas deferens, to elucidate the possible involvement of T-type voltage-gated Ca(2+) channels (VOCs) in the contractile function of the tissue.
Human vas deferens specimens from elective vasectomies were cut into strips of longitudinal muscle or transversely into rings of circular muscle. These were set up for tension recording and superfused with Krebs' medium (36 degrees C). Contractions were evoked by noradrenaline or high K(+) (in the presence of the L-type Ca(2+) agonist, FPL 64176) and the effects of Ca(2+) antagonists were determined.
Noradrenaline (0.1-100 micromol/L) evoked rhythmic and tonic contractions of longitudinal and circular muscles, which were potently inhibited by nifedipine (<or=0.1 micromol/L). Mibefradil (1-10 micromol/L) inhibited the contractions but was comparatively more effective in longitudinal than circular muscle. Flunarizine was ineffective except against contractions to low concentrations of noradrenaline. The drugs' potencies as antagonists of L-type VOCs were determined against contractions to high K(+) (120 mmol/L in the presence of FPL 64176, 1 micromol/L). The contractions in longitudinal and circular muscle had different times to peak and decline but were inhibited comparably by nifedipine (50% inhibitory concentration, IC(50), longitudinal and circular muscle, approximately 2 nmol/L) or by mibefradil (IC(50) longitudinal muscle, 1.1 micromol/L; circular muscle, 2.4 micromol/L) and were less sensitive to flunarizine (up to 30 micromol/L).
These results indicate that noradrenaline-induced contractions of human vas deferens depend primarily on nifedipine-sensitive L-type VOCs, as opposed to mibefradil/flunarizine-sensitive T-type VOCs. The effects of mibefradil and flunarizine, at concentrations found to be effective against noradrenaline-induced contractions, involve the blockade of L-type VOCs. The modest differential effect of mibefradil in longitudinal and circular muscle is discussed in relation to factors that modulate activation and drug-sensitivity of L-type VOCs.
研究相对选择性的 T 型钙通道拮抗剂米贝地尔和氟桂利嗪,以及 L 型钙通道拮抗剂硝苯地平对人输精管纵行肌和环形肌收缩的影响,以阐明 T 型电压门控钙通道(VOCs)可能参与组织的收缩功能。
从选择性输精管切除术获得的人输精管标本被切成纵行肌条或横向切成环形肌环。这些标本被建立张力记录,并在 Krebs 介质(36°C)中进行超灌流。通过去甲肾上腺素或高[K+](在 L 型钙激动剂 FPL 64176 的存在下)引发收缩,并确定钙拮抗剂的作用。
去甲肾上腺素(0.1-100 μmol/L)引发纵行和环形肌肉的节律性和紧张性收缩,硝苯地平(<0.1 μmol/L)强烈抑制这些收缩。米贝地尔(1-10 μmol/L)抑制收缩,但在纵行肌中比环形肌更有效。氟桂利嗪除了对抗低浓度去甲肾上腺素引起的收缩外,没有效果。这些药物作为 L 型 VOC 拮抗剂的效力是通过对高 K+(120 mmol/L,存在 FPL 64176,1 μmol/L)引发的收缩来确定的。纵行和环形肌肉的收缩有不同的峰值和下降时间,但硝苯地平(50%抑制浓度,IC50,纵行和环形肌肉,约 2 nmol/L)或米贝地尔(IC50 纵行肌,1.1 μmol/L;环形肌,2.4 μmol/L)的抑制作用相似,对氟桂利嗪的敏感性较低(高达 30 μmol/L)。
这些结果表明,人输精管去甲肾上腺素诱导的收缩主要依赖于硝苯地平敏感的 L 型 VOC,而不是米贝地尔/氟桂利嗪敏感的 T 型 VOC。在发现对去甲肾上腺素诱导的收缩有效的浓度下,米贝地尔和氟桂利嗪的作用涉及 L 型 VOC 的阻断。米贝地尔在纵行和环形肌肉中的适度差异作用与调节 L 型 VOC 激活和药物敏感性的因素有关。